Post-COVID-19 multisystem inflammatory syndrome: an evolving concept

被引:0
作者
Luiz Staub, Henrique [1 ]
Portella Staub, Lia [1 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Escola Med, Porto Alegre, RS, Brazil
关键词
multisystem inflammatory syndrome; Kawasaki disease; SARS-CoV-2; COVID-19; KAWASAKI-DISEASE; COVID-19; CHILDREN;
D O I
10.15448/1980-6108.2022.1.42436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: A potential association of COVID-19 with inflammatory and autoimmune phenomena opens a new chapter in clinical practice. Among several inflammatory conditions described in the post-COVID-19 context, Kawasaki disease and a new condition named multisystem inflammatory syndrome stand out. AIMS: To review, in a practical and concise way, the concept and diagnostic criteria of multisystem inflammatory syndrome, the overlaps with Kawasaki disease, as well as the immunopathogenesis and treatment of this new and intriguing condition. METHODS: Literature review available in the Pubmed database, with emphasis on systematic reviews with meta-analyses. RESULTS: The multisystem inflammatory syndrome is a post-viral, multiorgan hyperinflammatory disorder. The condition is primarily pediatric, and the first cases were reported in England in May 2020. Diagnostic criteria are still imprecise, and include some Kawasaki disease-like manifestations. However, multisystem inflammatory syndrome differs from Kawasaki disease by usually affecting children above five years of age and of black or hispanic races; in clinical terms, it is distinguished by the high frequency of gastroenteropathy, cardiomyopathy and shock. Differential diagnosis includes bacterial sepsis, macrophage activation syndrome, and systemic forms of rheumatoid arthritis. An overexpression of interferons and other inflammatory cytokines pathogenically characterize the multisystem inflammatory syndrome. The disease is, as a rule, responsive to intensive care, steroids, intravenous immunoglobulin, and immunobiologics. CONCLUSIONS: Multisystem inflammatory syndrome is a new and complex hyperinflammatory condition associated with previous exposure to SARS-CoV-2. It shows interesting interfaces with Kawasaki disease. Despite the recent description, the literature is already quantitatively robust, and some pending issues in immunopathogenesis, diagnostic criteria and therapy should be shortly clarified.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 53 条
  • [31] EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
    Ozen, S
    Ruperto, N
    Dillon, MJ
    Bagga, A
    Barron, K
    Davin, JC
    Kawasaki, T
    Lindsley, C
    Petty, RE
    Prieur, AM
    Ravelli, A
    Woo, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 936 - 941
  • [32] The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C)
    Panaro, Salvatore
    Cattalini, Marco
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [33] Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation
    Radia, Trisha
    Williams, Nia
    Agrawal, Pankaj
    Harman, Katharine
    Weale, Jonathan
    Cook, James
    Gupta, Atul
    [J]. PAEDIATRIC RESPIRATORY REVIEWS, 2021, 38 : 51 - 57
  • [34] Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital
    Ramcharan, Tristan
    Nolan, Oscar
    Lai, Chui Yi
    Prabhu, Nanda
    Krishnamurthy, Raghu
    Richter, Alex G.
    Jyothish, Deepthi
    Kanthimathinathan, Hari Krishnan
    Welch, Steven B.
    Hackett, Scott
    Al-Abadi, Eslam
    Scholefield, Barnaby R.
    Chikermane, Ashish
    [J]. PEDIATRIC CARDIOLOGY, 2020, 41 (07) : 1391 - 1401
  • [35] Hyperinflammatory shock in children during COVID-19 pandemic
    Riphagen, Shelley
    Gomez, Xabier
    Gonzalez-Martinez, Carmen
    Wilkinson, Nick
    Theocharis, Paraskevi
    [J]. LANCET, 2020, 395 (10237) : 1607 - 1608
  • [36] Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
    Rodriguez, Yhojan
    Novelli, Lucia
    Rojas, Manuel
    De Santis, Maria
    Acosta-Ampudia, Yeny
    Monsalve, Diana M.
    Ramirez-Santana, Carolina
    Costanzo, Antonio
    Ridgway, William M.
    Ansari, Aftab A.
    Gershwin, M. Eric
    Selmi, Carlo
    Anaya, Juan-Manuel
    [J]. JOURNAL OF AUTOIMMUNITY, 2020, 114
  • [37] Royal College of Paediatrics and Child Health (RCP-CH), 2020, GUID PAED MULT INFL
  • [38] Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
    Sardu, Celestino
    Gambardella, Jessica
    Morelli, Marco Bruno
    Wang, Xujun
    Marfella, Raffaele
    Santulli, Gaetano
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [39] Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
    Sharma, Chetan
    Ganigara, Madhusudan
    Galeotti, Caroline
    Burns, Joseph
    Berganza, Fernando M.
    Hayes, Denise A.
    Singh-Grewal, Davinder
    Bharath, Suman
    Sajjan, Sujata
    Bayry, Jagadeesh
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (12) : 731 - 748
  • [40] Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view
    Simon Junior, Hany
    Shimoda Sakano, Tania Miyuki
    Rodrigues, Regina Maria
    Eisencraft, Adriana Pasmanik
    Lemos de Carvalho, Vitor Emanoel
    Schvartsman, Claudio
    Afonso da Costa Reis, Amelia Gorete
    [J]. JORNAL DE PEDIATRIA, 2021, 97 (02) : 140 - 159